Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA479062
Max Phase: Preclinical
Molecular Formula: C26H42N2O3
Molecular Weight: 430.63
Molecule Type: Small molecule
Associated Items:
ID: ALA479062
Max Phase: Preclinical
Molecular Formula: C26H42N2O3
Molecular Weight: 430.63
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCN1CC(CCC(=O)O)c2c(C)cc(C)c(NC(=O)C(C)(C)C)c21
Standard InChI: InChI=1S/C26H42N2O3/c1-7-8-9-10-11-12-15-28-17-20(13-14-21(29)30)22-18(2)16-19(3)23(24(22)28)27-25(31)26(4,5)6/h16,20H,7-15,17H2,1-6H3,(H,27,31)(H,29,30)
Standard InChI Key: MTACVFYPFSKHEH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 430.63 | Molecular Weight (Monoisotopic): 430.3195 | AlogP: 6.42 | #Rotatable Bonds: 11 |
Polar Surface Area: 69.64 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.62 | CX Basic pKa: 3.47 | CX LogP: 6.86 | CX LogD: 4.37 |
Aromatic Rings: 1 | Heavy Atoms: 31 | QED Weighted: 0.40 | Np Likeness Score: -0.38 |
1. Takahashi K, Kasai M, Ohta M, Shoji Y, Kunishiro K, Kanda M, Kurahashi K, Shirahase H.. (2008) Novel indoline-based acyl-CoA:cholesterol acyltransferase inhibitor with antiperoxidative activity: improvement of physicochemical properties and biological activities by introduction of carboxylic acid., 51 (15): [PMID:18620381] [10.1021/jm800248r] |
Source(1):